Chinese biopharmaceutical company Zai Lab Ltd., backed by Chinese venture capital firms including Advantech, OrbiMed Asia Partners and Qiming Venture Partners, has completed an initial public offering on the NASDAQ in New York, raising approximately US$150 million in total.
Qiming Venture Partners has led a RMB120 million (US$18 million) series B round in Infervision, a Chinese artificial intelligence start-up developing medical imaging technology.
Chinese investment firm Yingke Private Equity has invested RMB100 million (US$14 million) in Shanghai Sanyou Medical Co., Ltd., an orthopedic medical device developer.
SinoVision Technologies (Beijing) Co., Ltd., a Chinese medical technology start-up developing computed tomography (CT) scanners, has raised a RMB200 million (US$29 million) new funding round from HG Capital, Qiming Venture Partners and little-known Chinese healthcare investment firm Yili Fuyi Daohe.
Abcfintech, a Chinese AI services provider targeting the financial services sector, has raised a total of US$30 million through an angel round and a series A round. Chinese venture capital firm Qiming Venture Partners led the round, with Source Code Capital, SIG Asia Investment and Welight Capital also participating, according to a company announcement.
Antengene Corporation, a Chinese clinical-stage biopharmaceutical company, has raised US$21 million in a series A financing round led by Qiming Venture Partners. Chinese investment firms TF Capital and HG Capital, as well as Tigermed Investment, also participated in the deal.
Chinese venture capital firm Qiming Venture Partners has led a US$20 million financing round in New Horizon Health, a Chinese precision health start-up focused on developing early-stage cancer screening technologies.
Bertelsmann Asia Investments (BAI) and Qiming Venture Partners have led a series A round worth tens of millions of U.S. dollars in Shiyunji, a food court operator that employs mobile and cloud technology to streamline both sales and purchasing.
China-focused venture capital firm Qiming Venture Partners has led a series A round of nearly US$10 million in Kuaile Zhihui, a Beijing-based artificial intelligence start-up developing educational robots for children.
China-focused venture capital firm Qiming Venture Partners has led a RMB175 million (US$25 million) series A round in QIAGEN (Suzhou) Translational Medicine Co., a Chinese precision medicine solutions provider.
China-focused venture capital firm Qiming Venture Partners has led a RMB200 million (US$29 million) series A round in Sino Biological Inc., a Beijing-based recombinant protein and antibody developer, according to a company announcement.
Venture Capital firm GGV Capital has led a series A investment round of over RMB100 million (US$14 million) in Bingobox, a Chinese start-up developing fully-automated convenience stores that operate similarly to Amazon Go, a checkout-free grocery store launched by Amazon.
Healthcare-focused investment firm OrbiMed Asia Partners has led a US$30 million series C round in Zai Lab Ltd., a Shanghai-based innovative biopharmaceutical company.
CCB International, an investment unit owned by China Construction Bank, and Chinese venture firm HG Capital have led a US$100 million series D round in Chubao Technology, a Shanghai-based mobile communication app developer.
CITIC Capital has led a RMB120 million (US$17 million) series B round in China Great Wall Environment Improving Co., Ltd, a energy saving and environmental protection services company, which is part of China Aerospace Science and Technology Corp.
Chinese venture capital firm Qiming Venture Partners has led a RMB120 million (US$17 million) series A round in XSky Beijing Data Technology Co Ltd, a company providing software-defined-infrastructure products and services.
Qiming Venture Partners and Legend Capital have led a RMB100 million (US$14.5 million) series B round in Qiang Sen International Community Medical (QSICM), a community clinic franchise operator based in Xianyang city in Shaanxi province.
Chinese medical and pharmaceutical-focused venture fund Bioventure Investment Management Ltd. has led an undisclosed series A+ round in Ark Biosciences, a Shanghai-based drug developer targeting respiratory viruses, influenza and Hepatitis B.
Vision Plus Capital, a Hangzhou-based venture capital firm managing RMB2 billion (US$290 million), has hired an ex-Temasek director and a former GGV Capital professional to lead its investments in the Internet, technology, healthcare and consumers sectors.
Chinese private equity firm Capital Today, Tencent Holding Ltd., Sogou, Inc., Qiming Venture Partners and Sinovation Ventures have invested US$100 million in a series D round in Zhihu, a question-and-answer knowledge sharing platform similar to Quora.
Meitu Inc., a photo retouch app developer backed by Qiming Venture Parnters, IDG Capital Partners and others, has completed offering 574 million shares priced at HK$8.50 apiece to raise net proceeds of approximately HK$4.688 billion (US$604 million).
Shanghai-based Chinese Yelp-like review website Dianping.com says it has received strategic investment from Tencent, according to a company announcement.